Berlin - Delayed Quote EUR

Aurinia Pharmaceuticals Inc (IKAP.BE)

Compare
8.59 -0.03 (-0.32%)
At close: December 23 at 8:13:02 AM GMT+1
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
220,361.00
175,513.00
134,030.00
45,605.00
50,118.00
Cost of Revenue
28,091.00
14,148.00
5,664.00
1,091.00
--
Gross Profit
192,270.00
161,365.00
128,366.00
44,514.00
50,118.00
Operating Expense
217,207.00
253,056.00
239,836.00
225,249.00
154,408.00
Operating Income
-24,937.00
-91,691.00
-111,470.00
-180,735.00
-104,290.00
Net Non Operating Interest Income Expense
12,551.00
14,222.00
5,118.00
529.00
1,516.00
Other Income Expense
--
--
--
--
-6,809.00
Pretax Income
-20,141.00
-77,469.00
-106,352.00
-180,206.00
-102,774.00
Tax Provision
2,411.00
551.00
1,828.00
760.00
-94.00
Net Income Common Stockholders
-22,552.00
-78,020.00
-108,180.00
-180,966.00
-102,680.00
Diluted NI Available to Com Stockholders
-22,552.00
-78,020.00
-108,180.00
-180,966.00
-102,680.00
Basic EPS
-0.15
-0.54
-0.76
-1.40
-0.87
Diluted EPS
-0.15
-0.54
-0.76
-1.40
-0.87
Basic Average Shares
143,437.00
143,236.00
141,915.00
129,369.00
118,473.00
Diluted Average Shares
144,679.75
143,236.00
141,915.00
129,369.00
118,473.00
Total Operating Income as Reported
-32,692.00
-91,691.00
-111,470.00
-180,735.00
-104,290.00
Total Expenses
245,298.00
267,204.00
245,500.00
226,340.00
154,408.00
Net Income from Continuing & Discontinued Operation
-22,552.00
-78,020.00
-108,180.00
-180,966.00
-102,680.00
Normalized Income
-16,425.55
-78,020.00
-108,180.00
-180,966.00
-102,680.00
Interest Income
17,550.00
16,997.00
5,118.00
529.00
1,516.00
Interest Expense
4,999.00
2,775.00
--
--
--
Net Interest Income
12,551.00
14,222.00
5,118.00
529.00
1,516.00
EBIT
-15,142.00
-74,694.00
-106,352.00
-180,206.00
-104,290.00
EBITDA
4,390.00
-63,047.00
-103,646.00
-177,445.00
-102,919.00
Reconciled Cost of Revenue
28,091.00
14,148.00
5,664.00
1,091.00
--
Reconciled Depreciation
19,532.00
11,647.00
2,706.00
2,761.00
1,371.00
Net Income from Continuing Operation Net Minority Interest
-22,552.00
-78,020.00
-108,180.00
-180,966.00
-102,680.00
Total Unusual Items Excluding Goodwill
-7,755.00
--
--
--
--
Total Unusual Items
-7,755.00
--
--
--
--
Normalized EBITDA
12,145.00
-63,047.00
-103,646.00
-177,445.00
-102,919.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-1,628.55
--
--
--
--
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade